col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


78 Results       Page 1

 [1] 
Wiley: Vox Sanguinis
  original article Date Title Authors   All Authors
1 [GO] 2025―Feb―04 Donors in the COVID-19 era: How did donor characteristics change in Japan? T. Odajima, N. H. Tsuno, R. Okubo, S. Makino, T. Miyagi, K. Ikuta, et al. (+2)
2 [GO] 2024―May―14 Immunoadsorption as a method of antibody donation during the COVID-19 pandemic Jannik Rothenburg, Silke Rink-Baron, Lisa Müller, Philipp Niklas Ostermann, Johannes C. Fischer, Derik Hermsen, et al. (+2)
3 [GO] 2024―Apr―05 SARS-CoV-2 immunoassays in a predominantly vaccinated population: Performances and qualitative agreements obtained with two analytical approaches and four immunoassays Christian Renaud, Antoine Lewin, Yves Gregoire, Nathalie Simard, Émilie Vallières, Maude Paquette, et al. (+6)
4 [GO] 2024―Mar―14 Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID-19 restriction in March 2020 Steven J. Drews, Carmen Charlton, Sheila F. O'Brien, Samantha Burugu, Gregory A. Denomme
5 [GO] 2023―Dec―29 The evolution and interpretation of seroprevalence of SARS-CoV-2 antibodies among South African blood donors from the Beta to Omicron variant-driven waves Marion Vermeulen, Laurette Mhlanga, Wendy Sykes, Russell Cable, Charl Coleman, Nadia Pietersen, et al. (+6)
6 [GO] 2023―Nov―22 Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial Irene Romera Martínez, Cristina Avendaño-Solá, Carolina Villegas Da Ros, Alba Bosch Llobet, José Antonio García Erce, María Isabel González Fraile, et al. (+15)
7 [GO] 2023―Oct―18 Two-phase Bayesian latent class analysis to assess diagnostic test performance in the absence of a gold standard: COVID-19 serological assays as a proof of concept Felix Camirand Lemyre, Sewanou Hermann Honfo, Chelsea Caya, Matthew P. Cheng, Karen Colwill, Rachel Corsini, et al. (+10)
8 [GO] 2023―Oct―11 Neutralization capacity of convalescent plasma against SARS-CoV-2 omicron sublineages: Implications for donor selection Reuben McGregor, Lauren Carlton, Aimee Paterson, Thomas Hills, Richard Charlewood, Nicole J. Moreland
9 [GO] 2023―Jul―04 Quality assessment and harmonization of laboratories across Europe for multiple SARS-CoV-2 serology assays Maurice Steenhuis, Elise Wouters, Hubert Schrezenmeier, Theo Rispens, Pierre Tiberghien, Heli Harvala, et al. (+2)
10 [GO] 2023―Mar―16 Comment on White paper on pandemic preparedness in the blood supply Veronica C. Hoad, Philip Kiely, Clive R. Seed, Iain B. Gosbell
11 [GO] 2023―Mar―16 Reply to Hoad et al. Comment on White paper on pandemic preparedness in the blood supply Paul Strengers, Sheila F. O'Brien, Constantina Politis, Wolfgang Mayr, Erhard Seifried, Bryan R. Spencer
12 [GO] 2023―Mar―10 Low neutralization capacity against SARS-CoV -2 Omicron BQ .1.1 of convalescent plasma collected during circulation of Omicron BA .1 Pierre Gallian, Nadége Brisbarre, Elif Nurtop, Sophie Le Cam, Touret Franck, Christine Isnard, et al. (+6)
13 [GO] 2023―Feb―03 Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID-19 convalescent plasma Irene Romera Martínez, José Luis Bueno Cabrera, José María Domingo-Morera, Juan Carlos López Aguilar, Carolina Villegas Da Ros, José Antonio García Erce, et al. (+14)
14 [GO] 2022―Nov―25 White paper on pandemic preparedness in the blood supply Paul Strengers, Sheila F. O'Brien, Constantina Politis, Wolfgang Mayr, Erhard Seifried, Bryan R. Spencer
15 [GO] 2022―Sep―14 Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility Arwa Z. Al-Riyami, Lise Estcourt, Naomi Rahimi-Levene, Evan M. Bloch, Ruchika Goel, Pierre Tiberghien, et al. (+14)
16 [GO] 2022―Sep―14 Haematological patients' perception of home transfusions: Effect of the COVID -19 pandemic Odit Gutwein, Katrin Herzog Tzarfati, Arie Apel, Naomi Rahimi-Levene, Hani Michaeli, Liza Barki-Harrington, Maya Koren-Michowitz
17 [GO] 2022―Aug―03 Unlikely influence of ABO blood group polymorphism on antibody response to COVID-19 mRNA vaccine against SARS-CoV -2 spike protein Fumiichiro Yamamoto, Emili Cid, Miyako Yamamoto, Eduardo Muñiz-Diaz
18 [GO] 2022―Aug―03 Response to ‘Unlikely influence of ABO blood group polymorphism on antibody response to COVID -19 mRNA vaccine against SARS-CoV -2 spike protein’ Valerio Bordino, Costanza Vicentini, Carla Maria Zotti
19 [GO] 2022―May―18 Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID -19 pandemic: A Canadian Blood Services Stem Cell Registry analysis David S. Allan, Meagan Green, Gail Morris, Jason Weiss, Nicholas Dibdin, Dena Mercer, Matthew Seftel
20 [GO] 2022―May―17 Reduced neutralizing antibody potency of COVID -19 convalescent vaccinated plasma against SARS-CoV -2 Omicron variant Pierre Gallian, Abdennour Amroun, Syria Laperche, Sophie Le Cam, Nadège Brisbarre, Lucile Malard, et al. (+6)
21 [GO] 2022―Mar―30 Reply to Jacobs et al.: Massive transfusion protocols during the COVID -19 pandemic Chih-Chun Chang, Jen-Tang Sun
22 [GO] 2022―Mar―30 Massive transfusion protocols during the COVID -19 pandemic Jeremy W. Jacobs, Brian D. Adkins, Garrett S. Booth
23 [GO] 2022―Mar―17 Plasma procurement and plasma product safety in light of the COVID -19 pandemic from the perspective of the plasma industry Peter L. Turecek, Deborah Hibbett, Thomas R. Kreil
24 [GO] 2022―Mar―08 International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID -19 pandemic Arwa Z. Al-Riyami, Thierry Burnouf, Erica M. Wood, Dana V. Devine, Adaeze Oreh, Torunn Oveland Apelseth, et al. (+37)
25 [GO] 2022―Feb―03 Impact of COVID -19 on blood donor deferral patterns during the COVID -19 pandemic: A retrospective analysis Suman Sudha Routray, Gopal Krushna Ray, Satya Prakash, Ansuman Sahu, Archana Naik, Somnath Mukherjee
26 [GO] 2022―Jan―13 Are convalescent plasma stocks collected during former COVID-19 waves still effective against current SARS-CoV -2 variants? Daniele Focosi, Massimo Franchini, Michael J. Joyner, Arturo Casadevall
27 [GO] 2022―Jan―13 Psychological impact of the COVID -19 pandemic on young professionals in blood banks and transfusion services: A global cross-sectional survey Arwa Z. Al-Riyami, Barbara Masser, Eszter Herczenik, Satyam Arora, Lilian Antwi Boateng, Carla Luana Dinardo, et al. (+5)
28 [GO] 2021―Dec―28 Does ABO blood group influence antibody response to SARS-CoV -2 vaccination? Costanza Vicentini, Valerio Bordino, Alessandro Roberto Cornio, Davide Meddis, Savina Ditommaso, Monica Giacomuzzi, et al. (+3)
29 [GO] 2021―Dec―13 COVID-19 convalescent plasma: Evolving strategies for serological screening in France Pierre Gallian, Sophie Le Cam, Nadège Brisbarre, Boris Pastorino, Abdennour Amroun, Lucile Malard, et al. (+5)
30 [GO] 2021―Dec―04 Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review Sahar Saeed, Samra Uzicanin, Antoine Lewin, Ryanne Lieshout-Krikke, Helen Faddy, Christian Erikstrup, et al. (+6)
31 [GO] 2021―Nov―24 Active seeking of post-donation information to minimize a potential threat to transfusion safety: A pilot programme in the context of the COVID-19 pandemic Antoine Lewin, Christian Renaud, Amélie Boivin, Marc Germain
32 [GO] 2021―Nov―02 Motivation, blood donor satisfaction and intention to return during the COVID -19 pandemic Christian Weidmann, Marie Derstroff, Harald Klüter, Martin Oesterer, Michael Müller-Steinhardt
33 [GO] 2021―Jun―14 Qualifying coronavirus disease 2019 convalescent plasma donors in Israel Marina Izak, Veronica Gendelman, Sharron Bransburg-Zabary, Evgeniy Stoyanov, Roni Gat, Daniel Cohen, et al. (+6)
34 [GO] 2021―Jun―10 The association of B blood group with SARS-CoV -2-induced death in Babol, north of Iran Saeed Hassani, Narges Kalantari, Seyedeh Farzaneh Jalali, Mahmood Shams, Zahra Ahmadnia, Meysam Aghajani Daroonkola, et al. (+2)
35 [GO] 2021―Jun―09 Management of children with glucose-6-phosphate dehydrogenase deficiency presenting with acute haemolytic crisis during the SARs-COV -2 pandemic Mohsen Elalfy, Amira Adly, Khadiga Eltonbary, Islam Elghamry, Omar Elalfy, Mohamed Maebid, et al. (+3)
36 [GO] 2021―May―20 International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary Arwa Z. Al-Riyami, Thierry Burnouf, Mark Yazer, Darrell Triulzi, Levent Tufan Kumaş, Levent Sağdur, et al. (+62)
37 [GO] 2021―May―20 International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses Arwa Z. Al-Riyami, Thierry Burnouf, Mark Yazer, Darrell Triulzi, Levent Tufan Kumaş, Levent Sağdur, et al. (+62)
38 [GO] 2021―Apr―09 Preservation of neutralizing antibody function in COVID-19 convalescent plasma treated using a riboflavin and ultraviolet light-based pathogen reduction technology Susan Yonemura, Lindsay Hartson, Taru S. Dutt, Marcela Henao-Tamayo, Raymond Goodrich, Susanne Marschner
39 [GO] 2021―Apr―09 Blood donation in times of crisis: Early insight into the impact of COVID-19 on blood donors and their motivation to donate across European countries Torsten Chandler, Sebastian Neumann-Böhme, Iryna Sabat, Pedro Pita Barros, Werner Brouwer, Job Exel, et al. (+3)
40 [GO] 2021―Apr―01 COVID-19 convalescent plasma therapy: hit fast, hit hard! Daniele Focosi, Massimo Franchini
41 [GO] 2021―Mar―27 Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic Silvano Wendel, Kevin Land, Dana V. Devine, James Daly, Renée Bazin, Pierre Tiberghien, et al. (+16)
42 [GO] 2021―Mar―18 Impact of pathogen reduction methods on immunological properties of the COVID-19 convalescent plasma Alexander I. Kostin, Maria N. Lundgren, Andrey Y. Bulanov, Elena A. Ladygina, Karina S. Chirkova, Alexander L. Gintsburg, et al. (+14)
43 [GO] 2021―Mar―17 Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices Gopal K. Patidar, Kevin J. Land, Hans Vrielink, Naomi Rahimi-Levene, Eldad J. Dann, Hind Al-Humaidan, et al. (+4)
44 [GO] 2021―Mar―02 Anti-A and SARS-CoV-2: an intriguing association Valeria Freitas Dutra, Carolina Bonet-Bub, Ana Paula H. Yokoyama, Ruth Achkar, Rafael Rahal Guaragna Machado, Murilo Assunção, et al. (+15)
45 [GO] 2021―Feb―26 Transfusion profile, clinical characteristics, comorbidities and outcomes of 3014 hospitalized patients diagnosed with COVID-19 in Brazil Leandro Felipe Figueiredo Dalmazzo, Alyne Ferreira Almendra Freitas, Brunna Eulálio Alves, Diogo Kloppel Cardoso, Eduardo Ferro Carvalho, Fabiana Akil, et al. (+11)
46 [GO] 2021―Feb―14 ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group Ruchika Goel, Evan M. Bloch, France Pirenne, Arwa Z. Al-Riyami, Elizabeth Crowe, Laetitia Dau, et al. (+18)
47 [GO] 2021―Feb―06 A survey of laboratory biosafety and protective measures in blood transfusion departments during the COVID-19 pandemic Haiting Liu, Leping Liu, Junhua Zhang, Xueling Shang, Sai Chen, Xisheng Li, et al. (+2)
48 [GO] 2021―Feb―06 Impact of the COVID-19 pandemic on blood supply and demand in the WHO African Region André Loua, Ossy Muganga Julius Kasilo, Jean Baptiste Nikiema, Aissatou Sarassa Sougou, Stanislav Kniazkov, Edith Andrews Annan
49 [GO] 2021―Feb―06 Association of the ABO blood group with SARS-CoV-2 infection in a community with low infection rate Taiwo R. Kotila, Temitope O. Alonge, Adeola Fowotade, Olufisayo I. Famuyiwa, Adebola S. Akinbile
50 [GO] 2021―Jan―25 ABO blood group and SARS-CoV-2 antibody response in a convalescent donor population Evan M. Bloch, Eshan U. Patel, Christi Marshall, Kirsten Littlefield, Ruchika Goel, Brenda J. Grossman, et al. (+12)
51 [GO] 2020―Dec―24 Evaluation of SARS-CoV-2 antibody titers and potency for convalescent plasma donation: a brief commentary Elise Wouters, Maurice Steenhuis, Hubert Schrezenmeier, Pierre Tiberghien, Heli Harvala, Hendrik B. Feys, Ellen Schoot
52 [GO] 2020―Dec―18 Subjects with blood group O are not at lower risk to acquire SARS-CoV-2 infection Nesrine Gamal, Erica Villa, Marco Rolli, Monica Pecorari, Giorgia Mirabella, Elisabetta Bertellini, et al. (+2)
53 [GO] 2020―Dec―13 Trends in blood donations, blood donors’ knowledge, practices and expectations during the COVID-19 pandemic in Cameroon Claude T. Tagny, Isabelle Lendem, Françoise Ngo Sack, Pauline Ngo Balogog, Catherine Ninmou, Ariane Dongmo, et al. (+6)
54 [GO] 2020―Dec―05 Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma Esam I. Azhar, Salwa I. Hindawi, Sherif A. El-Kafrawy, Ahmed M. Hassan, Ahmed M. Tolah, Thamir A. Alandijany, et al. (+2)
55 [GO] 2020―Nov―09 Research initiatives of blood services worldwide in response to the covid-19 pandemic Sheila F. O'Brien, Ryanne W. Lieshout-Krikke, Antoine Lewin, Christian Erikstrup, Whitney R. Steele, Samra Uzicanin, Brian Custer
56 [GO] 2020―Nov―02 Blood transfusion activity in a general hospital during the COVID-19 pandemic Karen Marín-Mori, Isabel González-Gascón y Marín, María-Ángeles Foncillas-García, Carolina Muñoz-Novas, María Infante, Juan Churruca-Sarasqueta, et al. (+4)
57 [GO] 2020―Oct―26 Lack of association between ABO blood groups and susceptibility to SARS-CoV-2 infection José Eduardo Levi, Paulo Roberto Telles, Hommenig Scrivani, Gustavo Campana
58 [GO] 2020―Oct―26 Blood supply management in times of SARS-CoV-2 pandemic - challenges, strategies adopted, and the lessons learned from the experience of a hospital-based blood centre Hem Chandra Pandey, Poonam Coshic, Chippy C S, Priyadarsini Jayachandran Arcot, Karan Kumar
59 [GO] 2020―Sep―30 Blood supply sufficiency and safety management in Iran during the COVID-19 outbreak Mahtab Maghsudlu, Peyman Eshghi, Sedigheh Amini Kafi-Abad, Abbas Sedaghat, Hossein Ranjbaran, Saeed Mohammadi, Seyed Morteza Tabatabai
60 [GO] 2020―Sep―23 Blood group ABO polymorphism inhibits SARS-CoV-2 infection and affects COVID-19 progression Fumiichiro Yamamoto, Miyako Yamamoto, Eduardo Muñiz-Diaz
61 [GO] 2020―Sep―23 Severe acute respiratory syndrome coronavirus-2: implications for blood safety and sufficiency Philip Kiely, Veronica C. Hoad, Clive R. Seed, Iain B. Gosbell
62 [GO] 2020―Sep―19 The protective effect of O blood type against SARS-CoV-2 infection Massimo Franchini, Claudia Glingani, Claudia Del Fante, Martina Capuzzo, Vincenza Di Stasi, Giulia Rastrelli, et al. (+3)
63 [GO] 2020―Jun―15 Blood donation and the global COVID-19 pandemic: areas for social science research Jennie Haw, Kelly Holloway, Barbara M Masser, Eva-Maria Merz, Rachel Thorpe
64 [GO] 2020―Jun―15 Clinical use of Convalescent Plasma in the COVID-19 pandemic; a transfusion-focussed gap analysis with recommendations for future research priorities Arwa Z. Al-Riyami, Richard Schäfer, Karin van der Berg, Evan M Bloch, Lise J. Escourt, Ruchika Goel, et al. (+8)
65 [GO] 2020―Jun―13 Guidance for the Procurement of COVID-19 Convalescent Plasma: Differences between High and Low-Middle Income Countries Evan M. Bloch, Ruchika Goel, Silvano Wendel, Thierry Burnouf, Arwa Z. Al-Riyami, Ai Leen Ang, et al. (+15)
66 [GO] 2020―Jun―09 Vox Sanguinis International Forum on Hospital Transfusion Services’ Response to COVID-19 Massimo Franchini, Giuseppe Marano, Claudio Velati, Ilaria Pati, Simonetta Pupella, Giancarlo Maria Liumbruno
67 [GO] 2020―Jun―09 Early experience with convalescent plasma as immunotherapy for COVID-19 in China: Knowns and unknowns Binzhen Chen, Rong Xia
68 [GO] 2020―May―28 Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety Jay Epstein, Martin Smid, Silvano Wendel, Daniel Somuah, Thierry Burnouf
69 [GO] 2020―May―14 Vox Sanguinis International Forum on Transfusion Services about Response to COVID-19 Miquel Lozano, Mark Yazer, Bryon Jackson, Monica Pagano, Naomi Rahimi-Levene, Victoria Peer, et al. (+23)
70 [GO] 2020―May―08 Vox Sanguinis International Forum on Transfusion Services about Response to COVID-19 Mark H. Yazer, Bryon Jackson, Monica Pagano, Naomi Rahimi-Levene, Victoria Peer, José Luis Bueno, et al. (+23)
71 [GO] 2020―Apr―29 Impact of COVID-19 on blood centres in Zhejiang province China Yongjun Wang, Wenjuan Han, Lingling Pan, Cuier Wang, Yan Liu, Wei Hu, et al. (+2)
72 [GO] 2020―Apr―22 Points to consider in the preparation and transfusion of COVID-19 convalescent plasma Jay Epstein, Thierry Burnouf
73 [GO] 2020―Apr―20 Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment Shawn D Keil, Izabela Ragan, Susan Yonemura, Lindsay Hartson, Nicole K Dart, Richard Bowen
74 [GO] 2020―Apr―09 Coronavirus-19 Disease (COVID-19) and Decrease in Blood Donation: Experience of Iranian Blood Transfusion Organization (IBTO) Saeed Mohammadi, Seyed Morteza Tabatabaei Yazdi, Peyman Eshghi, Amir Hossein Norooznezhad
75 [GO] 2020―Apr―02 Post-donation COVID-19 identification in blood donors So-Yong Kwon, Eun-Jin Kim, Yu Soek Jung, Jin Sung Jang, Nam-Sun Cho
76 [GO] 2020―Apr―02 Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how Pierre Tiberghien, Xavier de Lambalerie, Pascal Morel, Pierre Gallian, Karine Lacombe, Yazdan Yazdanpanah
77 [GO] 2020―Apr―02 The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy Massimo Franchini, Albert Farrugia, Claudio Velati, Alessandro Zanetti, Luisa Romanò, Giuliano Grazzini, et al. (+5)
78 [GO] 2020―Jan―13 Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light Markus Eickmann, Ute Gravemann, Wiebke Handke, Frank Tolksdorf, Stefan Reichenberg, Thomas H. Müller, Axel Seltsam
 [1] 

78 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec